NCT04961905

Pharmacokinetic Characteristics and Safety After Administration of NVP-2002

A Phase I Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and Safety After Administration of NVP-2002 and Co-administration of NVP-2002-R1 and NVP-2002-R2 in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 96 (actual)
• Sponsor: NVP Healthcare · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare and evaluate the pharmacokinetic characteristics and safety after administration of NVP-2002 and co-administration of NVP-2002-R1 and NVP-2002-R2 in healthy adult volunteers.

Detailed description

Phase 1 to evaluate the pharmacokinetic characteristics and safety after administration of NVP-2002 and co-administration of NVP-2002-R1 and NVP-2002-R2. Which is designed as ramdomized, oral, single dose, 2×2 crossover.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	NVP-2002-R1+NVP-2002-R2	NVP-2002-R1 1 tablet, once daily and NVP-2002-R2 1 tablet, once daily
DRUG	NVP-2002	NVP-2002 is a combination of NVP-2002-R1 and NVP-2002\_R2 NVP-2002, 1 tablet, once daily

Timeline

• Start date: 2022-09-03
• Primary completion: 2023-04-25
• Completion: 2023-05-30
• First posted: 2021-07-14
• Last updated: 2023-10-05

Locations

1 site across 1 country: South Korea